INNT
TOTAL INVALIDATION PROCESSED BY THE IB
06/20/2025
Back to search
Official data from USPTO
KANGSTEM BIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
06/21/2025
Trademark type
Combined
Nice classes
3, 5, 42
Filing date
07/20/2016
Registration date
12/26/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/12/2024
Last transaction
06/21/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
Seoul, KR
Examiner
CARROLL, DORITT
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "KANGSTEM BIOTECH" underneath Korean characters.
Holders and representatives
Holders
Kangstem Biotech CO., LTD.
Representatives
KIM, HEE SO KIM, HEE SO
Technical classification
Nice Classes
Class 3Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Body lotion; body milk; skin lotions; cosmetic creams for skin care; cosmetic preparations for skin care; skin cream; skin cleansers; eye cream; facial lotions; facial cream; face milk and lotions; face and body lotions; face and body milk; cosmetics for the face and body; lotions for face and body care; face and body creams; lotions for cosmetic purposes; cosmetics; cosmetic skin milk lotions
Class 5
Pharmaceutical preparations for immunity adjustment; vaccines; cord blood for medical use; allergy medications; Skin lotions for pharmaceutical purposes; ointments for pharmaceutical purposesantibiotic ointmentsanti-inflammatory ointmentsanti-itch ointment; chemico-pharmaceutical preparations for the treatment of cancer; pharmaceutical agents for epidermis; microorganism preparation for medical and veterinary purposes; bacterial preparations for medical and veterinary purposes; stem cells for medical purposes; dermatological pharmaceutical products; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for the treatment of cells; preparations for treatment of cancer; biological preparations for medical and clinical purposesbeing extracted from stem cellsstem cell tissuesstem cell tissue scaffolds and the combinations thereofall for the treatment of cancer; drugs for medical and clinical purposesbeing extracted from stem cellsstem cell tissuesstem cell tissue scaffolds and the combinations thereofall for the treatment of cancer; pharmaceutical preparation for treatment of auto-immune diseases; stem cell medicine; bouillons for stem cultures
Class 42
Cosmetology research; research and development of vaccines and medicines; biotechnology research; advisory services relating to biotechnology; research on cancer; pharmaceutical products development; research on the subject of pharmaceuticals; research in the field of gene analysis; genetic research; research for medical products; medical research; product safety testing; quality control for others; cosmetic research; research services in the field of cosmetics; survey services in the nature of technical consulting regarding pharmaceutical studies in the field of cosmetics; development of cell therapy products; stem cell collection for medical research purposes; stem cell testing for medical research purposes
Publications
History of USPTO decisions and trademark events.
39 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
05/31/2025
INPC
INVALIDATION PROCESSED
05/31/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
03/12/2025
C71T
CANCELLED SECTION 71
07/12/2024
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
11/07/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/19/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/30/2018
FIMP
FINAL DISPOSITION PROCESSED
03/30/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/26/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
12/26/2017
GPNX
NOTIFICATION PROCESSED BY IB
10/21/2017
PUBO
PUBLISHED FOR OPPOSITION
10/10/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/04/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/04/2017
NPUB
NOTICE OF PUBLICATION
09/20/2017
CNEA
EXAMINERS AMENDMENT MAILED
09/05/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/01/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
09/01/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/01/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
09/01/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
08/22/2017
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
08/10/2017
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
07/28/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/17/2017
DOCK
ASSIGNED TO EXAMINER
07/16/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/12/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/12/2017
ALIE
ASSIGNED TO LIE
06/08/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/12/2017
RFNT
REFUSAL PROCESSED BY IB
12/30/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/12/2016
RFRR
REFUSAL PROCESSED BY MPU
12/12/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/11/2016
CNRT
NON-FINAL ACTION WRITTEN
12/10/2016
MAFR
APPLICATION FILING RECEIPT MAILED
12/06/2016
DOCK
ASSIGNED TO EXAMINER
12/02/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/02/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/01/2016
Continuous trademark protection
Get notified about every new filing that threatens KANGSTEM BIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.